Restatement of Previously Issued Financial Statements (Details - Restatement adjustments) - USD ($) | 3 Months Ended | 9 Months Ended |
Sep. 30, 2024 | Jun. 30, 2024 | Mar. 31, 2024 | Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2024 | Sep. 30, 2023 |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | | | | | | | | |
Revenue | $ 1,531,264 | | | $ 0 | | | $ 3,561,303 | $ 0 |
Cost of goods sold | 1,131,777 | | | 0 | | | 2,569,209 | 0 |
Gross profit | 399,487 | | | 0 | | | 992,094 | 0 |
Operating expenses: | | | | | | | | |
Research and development | 15,000 | | | 0 | | | 42,078 | 0 |
General and administrative | 1,374,989 | | | 353,029 | | | 3,728,749 | 1,965,469 |
Depreciation and amortization | 171 | | | 645 | | | 513 | 1,407 |
Total operating expenses | 1,860,539 | | | 353,674 | | | 5,111,203 | 1,966,876 |
Loss from operations | (1,461,052) | | | (353,674) | | | (4,119,109) | (1,966,876) |
Other income: | | | | | | | | |
Total other income | (683,198) | | | 0 | | | (743,381) | 0 |
Net loss | $ (2,144,250) | $ (1,612,238) | $ (1,106,002) | $ (353,674) | $ (435,298) | $ (1,177,904) | $ (4,862,490) | $ (1,966,876) |
Net loss per share attributable to common stockholders basic | $ (0.30) | | | $ (0.11) | | | $ (0.63) | $ (0.59) |
Net loss per share attributable to common stockholders diluted | $ (0.30) | | | $ (0.11) | | | $ (0.63) | $ (0.59) |
Weighted average common shares outstanding basic | 7,147,866 | | | 3,217,255 | | | 7,749,285 | 3,337,402 |
Weighted average common shares outstanding diluted | 7,147,866 | | | 3,217,255 | | | 7,749,285 | 3,337,402 |
Beginning balance, value | $ 19,971,821 | 21,222,816 | 1,414,919 | $ 2,185,179 | 2,620,477 | 3,198,381 | $ 1,414,919 | $ 3,198,381 |
Issuance of common shares | | | | | | 600,000 | | |
Conversion to preferred shares | | | | | | | | |
Ending balance, value | 19,226,002 | 19,971,821 | 21,222,816 | 1,831,505 | 2,185,179 | 2,620,477 | 19,226,002 | 1,831,505 |
Cash flows from operating activities: | | | | | | | | |
Depreciation | | | | | | | 513 | 1,407 |
Stock compensation expense | | | | | | | 759,673 | 0 |
Change in assets and liabilities: | | | | | | | | |
Accounts receivable | | | | | | | 73,109 | 0 |
Other current assets | | | | | | | 29,100 | (33,750) |
Accounts payable and accrued expenses | | | | | | | 630,595 | (50,819) |
Net cash used in operating activities | | | | | | | (2,718,513) | (1,382,538) |
Cash flows from investing activities | | | | | | | | |
Purchases of property and equipment | | | | | | | 0 | (3,164) |
Net cash used in investing activities | | | | | | | (852,801) | (3,164) |
Cash flows from financing activities: | | | | | | | | |
Net cash provided by financing activities | | | | | | | 4,362,313 | (376,702) |
Net increase (decrease) in cash | | | | | | | 790,999 | (1,762,404) |
Cash, beginning of period | | | 894,773 | | | 3,099,422 | 894,773 | 3,099,422 |
Cash, end of period | 1,685,772 | | | 1,337,018 | | | $ 1,685,772 | $ 1,337,018 |
Common Stock [Member] | | | | | | | | |
Other income: | | | | | | | | |
Net loss | | | | | | | | |
Beginning balance, shares | 10,411,240 | 9,333,341 | 3,217,255 | 3,217,255 | 3,467,255 | 3,392,250 | 3,217,255 | 3,392,250 |
Beginning balance, value | $ 104,113 | $ 93,334 | $ 32,173 | $ 32,173 | $ 34,673 | $ 33,923 | $ 32,173 | $ 33,923 |
Issuance of common shares, shares | | | | | | 75,005 | | |
Issuance of common shares | | | | | | $ 750 | | |
Conversion to preferred shares, shares | | 100,000 | 600,000 | | (250,000) | | | |
Conversion to preferred shares | | $ 1,000 | $ 6,000 | | $ (2,500) | | | |
Ending balance, shares | 6,184,983 | 10,411,240 | 9,333,341 | 3,217,255 | 3,217,255 | 3,467,255 | 6,184,983 | 3,217,255 |
Ending balance, value | $ 61,850 | $ 104,113 | $ 93,334 | $ 32,173 | $ 32,173 | $ 34,673 | $ 61,850 | $ 32,173 |
Additional Paid-in Capital [Member] | | | | | | | | |
Other income: | | | | | | | | |
Net loss | | | | | | | | |
Beginning balance, value | 26,518,993 | 26,168,529 | 5,315,790 | 5,315,790 | 5,313,291 | 4,714,041 | 5,315,790 | 4,714,041 |
Issuance of common shares | | | | | | 599,250 | | |
Conversion to preferred shares | | (1,000) | (5,999) | | 2,499 | | | |
Ending balance, value | 27,959,642 | 26,518,993 | 26,168,529 | 5,315,790 | 5,315,790 | 5,313,291 | 27,959,642 | 5,315,790 |
Retained Earnings [Member] | | | | | | | | |
Other income: | | | | | | | | |
Net loss | (2,144,250) | (1,612,238) | (1,106,002) | (353,674) | (435,298) | (1,177,904) | | |
Beginning balance, value | (6,651,286) | (5,039,048) | (3,933,046) | (3,162,786) | (2,727,488) | (1,549,584) | (3,933,046) | (1,549,584) |
Issuance of common shares | | | | | | | | |
Conversion to preferred shares | | | | | | | | |
Ending balance, value | $ (8,795,536) | $ (6,651,286) | $ (5,039,048) | (3,516,460) | $ (3,162,786) | (2,727,488) | $ (8,795,536) | (3,516,460) |
Previously Reported [Member] | | | | | | | | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | | | | | | | | |
Revenue | | | | | | | | 0 |
Cost of goods sold | | | | | | | | 0 |
Gross profit | | | | | | | | 0 |
Operating expenses: | | | | | | | | |
Research and development | | | | | | | | 0 |
General and administrative | | | | | | | | 1,376,462 |
Depreciation and amortization | | | | | | | | 1,407 |
Total operating expenses | | | | | | | | 1,377,869 |
Loss from operations | | | | | | | | (1,377,869) |
Other income: | | | | | | | | |
Interest income | | | | | | | | 0 |
Total other income | | | | | | | | 0 |
Net loss before income tax | | | | | | | | (1,377,869) |
Income tax benefit (expense) | | | | | | | | 0 |
Net loss | | | | | | | | $ (1,377,869) |
Net loss per share attributable to common stockholders basic | | | | | | | | $ (0.41) |
Net loss per share attributable to common stockholders diluted | | | | | | | | $ (0.41) |
Weighted average common shares outstanding basic | | | | | | | | 3,337,402 |
Weighted average common shares outstanding diluted | | | | | | | | 3,337,402 |
Beginning balance, value | | | | | | 3,209,374 | | $ 3,209,374 |
Ending balance, value | | | | 1,831,505 | | | | 1,831,505 |
Cash flows from operating activities: | | | | | | | | |
Depreciation | | | | | | | | 1,407 |
Stock compensation expense | | | | | | | | 0 |
Change in assets and liabilities: | | | | | | | | |
Accounts receivable | | | | | | | | 0 |
Deferred offering costs | | | | | | | | (376,702) |
Other current assets | | | | | | | | 33,750 |
Accounts payable and accrued expenses | | | | | | | | (39,826) |
Net cash used in operating activities | | | | | | | | (1,759,240) |
Cash flows from investing activities | | | | | | | | |
Purchases of property and equipment | | | | | | | | (3,164) |
Net cash used in investing activities | | | | | | | | (3,164) |
Cash flows from financing activities: | | | | | | | | |
Deferred offering costs | | | | | | | | 0 |
Net cash provided by financing activities | | | | | | | | 0 |
Net increase (decrease) in cash | | | | | | | | (1,762,404) |
Cash, beginning of period | | | | | | $ 3,099,422 | | 3,099,422 |
Cash, end of period | | | | $ 1,337,018 | | | | 1,337,018 |
Supplemental disclosures of cash flow information: | | | | | | | | |
Cash paid for interest | | | | | | | | 0 |
Cash paid for income tax | | | | | | | | $ 0 |
Previously Reported [Member] | Series B Preferred Stock [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, shares | | | | | | 140 | | 140 |
Beginning balance, value | | | | | | $ 1 | | $ 1 |
Conversion to preferred shares, shares | | | | | | | | 50 |
Conversion to preferred shares | | | | | | | | $ 1 |
Ending balance, shares | | | | 190 | | | | 190 |
Ending balance, value | | | | $ 2 | | | | $ 2 |
Previously Reported [Member] | Common Stock [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, shares | | | | | | 3,392,250 | | 3,392,250 |
Beginning balance, value | | | | | | $ 33,923 | | $ 33,923 |
Issuance of common shares, shares | | | | | | | | 75,005 |
Issuance of common shares | | | | | | | | $ 750 |
Conversion to preferred shares, shares | | | | | | | | (250,000) |
Conversion to preferred shares | | | | | | | | $ (2,500) |
Ending balance, shares | | | | 3,217,255 | | | | 3,217,255 |
Ending balance, value | | | | $ 32,173 | | | | $ 32,173 |
Previously Reported [Member] | Additional Paid-in Capital [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, value | | | | | | 4,714,041 | | 4,714,041 |
Issuance of common shares | | | | | | | | (750) |
Conversion to preferred shares | | | | | | | | 2,499 |
Ending balance, value | | | | 4,715,790 | | | | 4,715,790 |
Previously Reported [Member] | Stocks To Be Issued [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, value | | | | | | 0 | | 0 |
Ending balance, value | | | | 0 | | | | 0 |
Previously Reported [Member] | Retained Earnings [Member] | | | | | | | | |
Other income: | | | | | | | | |
Net loss | | | | | | | | (1,377,869) |
Beginning balance, value | | | | | | (1,538,591) | | (1,538,591) |
Ending balance, value | | | | (2,916,460) | | | | (2,916,460) |
Revision of Prior Period, Adjustment [Member] | | | | | | | | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | | | | | | | | |
Revenue | | | | | | | | 0 |
Cost of goods sold | | | | | | | | 0 |
Gross profit | | | | | | | | 0 |
Operating expenses: | | | | | | | | |
Research and development | | | | | | | | 0 |
General and administrative | | | | | | | | 589,007 |
Depreciation and amortization | | | | | | | | 0 |
Total operating expenses | | | | | | | | 589,007 |
Loss from operations | | | | | | | | (589,007) |
Other income: | | | | | | | | |
Interest income | | | | | | | | 0 |
Total other income | | | | | | | | 0 |
Net loss before income tax | | | | | | | | (589,007) |
Income tax benefit (expense) | | | | | | | | 0 |
Net loss | | | | | | | | $ (589,007) |
Net loss per share attributable to common stockholders basic | | | | | | | | $ (0.17) |
Net loss per share attributable to common stockholders diluted | | | | | | | | $ (0.17) |
Weighted average common shares outstanding basic | | | | | | | | 0 |
Weighted average common shares outstanding diluted | | | | | | | | 0 |
Beginning balance, value | | | | | | (10,993) | | $ (10,993) |
Issuance of common shares | | | | | | | | 600,000 |
Ending balance, value | | | | 0 | | | | 0 |
Cash flows from operating activities: | | | | | | | | |
Depreciation | | | | | | | | 0 |
Stock compensation expense | | | | | | | | 600,000 |
Change in assets and liabilities: | | | | | | | | |
Accounts receivable | | | | | | | | 0 |
Deferred offering costs | | | | | | | | 376,702 |
Other current assets | | | | | | | | 0 |
Accounts payable and accrued expenses | | | | | | | | (10,993) |
Net cash used in operating activities | | | | | | | | 376,702 |
Cash flows from investing activities | | | | | | | | |
Purchases of property and equipment | | | | | | | | 0 |
Net cash used in investing activities | | | | | | | | 0 |
Cash flows from financing activities: | | | | | | | | |
Deferred offering costs | | | | | | | | (376,702) |
Net cash provided by financing activities | | | | | | | | (376,702) |
Net increase (decrease) in cash | | | | | | | | 0 |
Cash, beginning of period | | | | | | $ 0 | | 0 |
Cash, end of period | | | | $ 0 | | | | 0 |
Supplemental disclosures of cash flow information: | | | | | | | | |
Cash paid for interest | | | | | | | | 0 |
Cash paid for income tax | | | | | | | | $ 0 |
Revision of Prior Period, Adjustment [Member] | Series B Preferred Stock [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, shares | | | | | | 0 | | 0 |
Beginning balance, value | | | | | | $ 0 | | $ 0 |
Ending balance, shares | | | | 0 | | | | 0 |
Ending balance, value | | | | $ 0 | | | | $ 0 |
Revision of Prior Period, Adjustment [Member] | Common Stock [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, shares | | | | | | 0 | | 0 |
Beginning balance, value | | | | | | $ 0 | | $ 0 |
Ending balance, shares | | | | 0 | | | | 0 |
Ending balance, value | | | | $ 0 | | | | $ 0 |
Revision of Prior Period, Adjustment [Member] | Additional Paid-in Capital [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, value | | | | | | 0 | | 0 |
Issuance of common shares | | | | | | | | 600,000 |
Ending balance, value | | | | 600,000 | | | | 600,000 |
Revision of Prior Period, Adjustment [Member] | Stocks To Be Issued [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, value | | | | | | 0 | | 0 |
Ending balance, value | | | | 0 | | | | 0 |
Revision of Prior Period, Adjustment [Member] | Retained Earnings [Member] | | | | | | | | |
Other income: | | | | | | | | |
Net loss | | | | | | | | (589,007) |
Beginning balance, value | | | | | | (10,993) | | (10,993) |
Ending balance, value | | | | (600,000) | | | | (600,000) |
As Restated [Member] | | | | | | | | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | | | | | | | | |
Revenue | | | | | | | | 0 |
Cost of goods sold | | | | | | | | 0 |
Gross profit | | | | | | | | 0 |
Operating expenses: | | | | | | | | |
Research and development | | | | | | | | 0 |
General and administrative | | | | | | | | 1,965,469 |
Depreciation and amortization | | | | | | | | 1,407 |
Total operating expenses | | | | | | | | 1,966,876 |
Loss from operations | | | | | | | | (1,966,876) |
Other income: | | | | | | | | |
Interest income | | | | | | | | 0 |
Total other income | | | | | | | | 0 |
Net loss before income tax | | | | | | | | (1,966,876) |
Income tax benefit (expense) | | | | | | | | 0 |
Net loss | | | | | | | | $ (1,966,876) |
Net loss per share attributable to common stockholders basic | | | | | | | | $ (0.59) |
Net loss per share attributable to common stockholders diluted | | | | | | | | $ (0.59) |
Weighted average common shares outstanding basic | | | | | | | | 3,337,402 |
Weighted average common shares outstanding diluted | | | | | | | | 3,337,402 |
Beginning balance, value | | | | | | 3,198,381 | | $ 3,198,381 |
Issuance of common shares | | | | | | | | 600,000 |
Ending balance, value | | | | 1,831,505 | | | | 1,831,505 |
Cash flows from operating activities: | | | | | | | | |
Depreciation | | | | | | | | 1,407 |
Stock compensation expense | | | | | | | | 600,000 |
Change in assets and liabilities: | | | | | | | | |
Accounts receivable | | | | | | | | 0 |
Deferred offering costs | | | | | | | | 0 |
Other current assets | | | | | | | | 33,750 |
Accounts payable and accrued expenses | | | | | | | | (50,819) |
Net cash used in operating activities | | | | | | | | (1,382,538) |
Cash flows from investing activities | | | | | | | | |
Purchases of property and equipment | | | | | | | | (3,164) |
Net cash used in investing activities | | | | | | | | (3,164) |
Cash flows from financing activities: | | | | | | | | |
Deferred offering costs | | | | | | | | (376,702) |
Net cash provided by financing activities | | | | | | | | (376,702) |
Net increase (decrease) in cash | | | | | | | | (1,762,402) |
Cash, beginning of period | | | | | | $ 3,099,422 | | 3,099,422 |
Cash, end of period | | | | $ 1,337,018 | | | | 1,337,018 |
Supplemental disclosures of cash flow information: | | | | | | | | |
Cash paid for interest | | | | | | | | 0 |
Cash paid for income tax | | | | | | | | $ 0 |
As Restated [Member] | Series B Preferred Stock [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, shares | | | | | | 140 | | 140 |
Beginning balance, value | | | | | | $ 1 | | $ 1 |
Conversion to preferred shares, shares | | | | | | | | 50 |
Conversion to preferred shares | | | | | | | | $ 1 |
Ending balance, shares | | | | 190 | | | | 190 |
Ending balance, value | | | | $ 2 | | | | $ 2 |
As Restated [Member] | Common Stock [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, shares | | | | | | 3,392,250 | | 3,392,250 |
Beginning balance, value | | | | | | $ 33,923 | | $ 33,923 |
Issuance of common shares, shares | | | | | | | | 75,005 |
Issuance of common shares | | | | | | | | $ 750 |
Conversion to preferred shares, shares | | | | | | | | (250,000) |
Conversion to preferred shares | | | | | | | | $ (2,500) |
Ending balance, shares | | | | 3,217,255 | | | | 3,217,255 |
Ending balance, value | | | | $ 32,173 | | | | $ 32,173 |
As Restated [Member] | Additional Paid-in Capital [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, value | | | | | | 4,714,041 | | 4,714,041 |
Issuance of common shares | | | | | | | | 599,250 |
Conversion to preferred shares | | | | | | | | 2,499 |
Ending balance, value | | | | 5,315,790 | | | | 5,315,790 |
As Restated [Member] | Stocks To Be Issued [Member] | | | | | | | | |
Other income: | | | | | | | | |
Beginning balance, value | | | | | | 0 | | 0 |
Ending balance, value | | | | 0 | | | | 0 |
As Restated [Member] | Retained Earnings [Member] | | | | | | | | |
Other income: | | | | | | | | |
Net loss | | | | | | | | (1,966,876) |
Beginning balance, value | | | | | | $ (1,549,584) | | (1,549,584) |
Ending balance, value | | | | $ (3,516,460) | | | | $ (3,516,460) |